Human Models for Predictable Drug Discovery
Drug discovery is a long and expensive process: screening for exciting new compounds is inexact, few make it to trials, patients respond to drugs differently, and side-effects are common.
A New Era in Drug Discovery with OsteoMimic
At Navigate Precision Biology, we offer a protected platform technology that produces precise, human-relevant disease models at scale, starting with bone disease. With upcoming models for kidney, heart, and lung conditions, we deliver human-like spheroids and organoids for faster development of novel therapeutics with predictable biological responses.
OsteoMimic offers a transformative solution for drug screening research using spheroids.
Human-Relevant Drug Screening
Rapid and Reliable Results
Cost and Time Efficiency
Faster Market Delivery
Advanced Instruments
Advanced Instruments
Laboratory Specialists
Laboratory Specialists
Bone Analysis
How it Works
Explore Our Core Technology:Â NaviPlate
NaviPlate 384-well plates to culture 3D spheroids and organoids
- SBS format
- One microcavity per well
- Flexible to accommodate a variety of readouts
* Registered design rights to NaviPlate in GB, EU and US (pending)
British Registered Design Number 6197224 and 6197225
EU Registered Design Number 009176944-0001 and 009176944-0002
US Design Application Number 29/853610
Cutting-Edge Technology Behind OsteoMimic
Predictable Drug Discovery
At the heart of our high-throughput platform is the pioneering NaviPlate technology, designed to test and cultivate bone forming spheroids with precision and efficiency. Our technology features:
Bone Forming Spheroids
Designed for high translatability, closely mimicking human bone regeneration.
Scalable and Reproducible Design
Ensures consistent data output across tests, facilitating reliable and scalable research.
Accelerated Bone Regeneration
Bone regeneration is achieved in just one week, compared to the traditional 4-5 weeks required by conventional 2D systems.
3R Principles
Reduces animal model dependency, aligning with modern sustainable and ethical research practices.
Cost and Resource Efficiency
Minimises the need for extensive space, resources, and staffing, making research more accessible and cost-effective.
Listen to Elad Katz, founder and CTO of Navigate Precision Biology, as he introduces the groundbreaking NaviPlate technology. An innovation in transforming drug discovery and organoid research.
Our Customised Solutions
Dedicated to discovering new and better drugs for patients with chronic diseases
Contract Research Organisations
Your Partner for Reliable, Efficient Preclinical Studies.
Consistent Spheroid Models
Efficient
Complement Animal Testing
Scalability
Pharmaceutical Companies
Boost Your Drug Discovery Pipeline with Effective Hit Identification.
High-Translatability Models
Diverse Testing Capabilities
Time Efficiency
Cost Effective
Research Institutions
Empowering Novel drug discovery with Advanced 3D Spheroid Models.Â
Human-relevant testing models
Enhanced Translatability
Collaborative Potential
Ethical Research Practises
3D Models
Developing Models for Kidney, Heart, and Lung conditions.
Navigate Precision Biology is expanding its innovative platform technology to develop advanced disease models for kidney, heart, and lung conditions. Building on our work with bone disease, our human-relevant spheroids and organoids provide a scalable solution for accelerating drug discovery with predictable biological responses. Get in touch to learn more about our upcoming models.
Heart Organoids
Kidney Organoids
Lung Organoids
Help Shape the Future of Bone Research and Drug Discovery
Please take a moment to share your perspective of the use of spheroids/ organoids in drug discovery by completing our survey!
Navigate Precision Biology
Our Team
DR. GARY EVANS
CEO
Dr. MOHAMMAD ISLAM
Co-inventor/ CSO
DR. ELAD KATZ
Founder/ CTO
Kashish Sarin
CMO
Want to hear more about our technology? Get in touch below
